Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00360932 · ClinicalTrials.gov registry record
Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study)
A clinical trial, sponsored by Bausch Health Americas.
- Completed
- Registry status
- 290
- Enrollment target
NCT00360932: Completed study, sponsored by Bausch Health Americas.
NCT00360932 is a clinical trial that has completed, run by Bausch Health Americas. The registered enrollment target is 290 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00360932 has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- 290 participants
- Enrollment target
Study Summary
5 year, open-label study to evaluate safety of SCULPTRA on the signs of lipoatrophy of the face in at least 100 evaluable subjects with human immunodeficiency virus.
Interventions
- DEVICE SCULPTRA (poly-L-lactic acid injection)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2005-10 |
| Est. Completion | 2011-08 |
What the finished NCT00360932 record still lists
NCT00360932 is an observational study that tracks outcomes without assigning an intervention. The registered 290 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which SCULPTRA (poly-L-lactic acid injection) is the first listed.
NCT00360932 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00360932 about?
NCT00360932 is a clinical study titled "Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study)". 5 year, open-label study to evaluate safety of SCULPTRA on the signs of lipoatrophy of the face in at least 100 evaluable subjects with human immunodeficiency virus.
What is the current status of trial NCT00360932?
This trial is currently completed. The enrollment target is 290 participants. The study started on 2005-10. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00360932?
The interventions under investigation include: SCULPTRA (poly-L-lactic acid injection) (DEVICE).
Who is sponsoring clinical trial NCT00360932?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
- NCT04649008 · 290 participants · Early Phase 1
Localizing Epileptic Networks Using MRI and iEEG
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia